The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) monitoring in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin +/- pembrolizumab (EVP).
 
Kevin Reyes
No Relationships to Disclose
 
Tanya Jindal
No Relationships to Disclose
 
Beaux Mitchell
Employment - Trial Library
Consulting or Advisory Role - Trial Library
 
Xiaolin Zhu
Employment - Exelixis (I)
 
Chien-Kuang Ding
Research Funding - Bristol Myers Squibb Foundation (Inst); Intuitive Surgical (Inst)
 
Arpita Desai
Honoraria - AVEO; OncLive/MJH Life Sciences; Targeted Oncology; Targeted Oncology
Consulting or Advisory Role - Aveo; Dendreon; Exelixis; Exelixis; Janssen; Janssen; Janssen Oncology; Merck
Research Funding - Exelixis (Inst); Merck
 
Anthony Wong
No Relationships to Disclose
 
Noah Younger
No Relationships to Disclose
 
Daniel Kwon
No Relationships to Disclose
 
Ivan de Kouchkovsky
Consulting or Advisory Role - Janssen
 
Elizabeth Pan
No Relationships to Disclose
 
Rahul Aggarwal
Consulting or Advisory Role - Alessa Therapeutics; Amgen; AstraZeneca; Bayer; BioXcel Therapeutics; Boxer Capital; Curio Science; EcoR1 Capital; Exelixis; Flare Therapeutics; Guidepoint Inc; Harpoon therapeutics; Janssen; Merck; MJH Life Sciences; Novartis; PCCTC; Pfizer; Research to Practice; Slingshot Insights; Tersera; Washington Research Foundation
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
Expert Testimony - University of Utah Health
Travel, Accommodations, Expenses - DAVA Oncology
 
Kelly Fitzgerald
Consulting or Advisory Role - Janssen; MJH Life Sciences
 
Carissa Chu
No Relationships to Disclose
 
Sima Porten
Honoraria - American Urologic Association; Exact Sciences; Pacific Edge
Consulting or Advisory Role - AstraZeneca; Oncuria; Photocure; Stryker
Research Funding - Photocure (Inst)
 
Steven Seyedin
No Relationships to Disclose
 
Eric Small
Stock and Other Ownership Interests - Fortis; Teon Therapeutics
 
Terence Friedlander
Honoraria - Abbvie; Astellas Pharma; EMD Serono; Merck
Consulting or Advisory Role - AADi; Astellas Pharma; Atkis; Bicycle Therapeutics; Bristol-Myers Squibb/Medarex; EMD Serono; Gilead Sciences; Janssen; Merck; Pfizer
Research Funding - Bicycle Therapeutics; Bristol-Myers Squibb (Inst); Neon Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bicycle Therapeutics; Merck
 
Jonathan Chou
Consulting or Advisory Role - Bicycle Therapeutics; Exai Bio
Research Funding - Amgen (Inst)
 
Vadim Koshkin
Consulting or Advisory Role - Astellas Pharma; Bicycle Therapeutics; Bristol Myers Squibb Foundation; Janssen; Loxo; Merck; MSD; Pfizer; Roche/Genentech; Tempus
Research Funding - Curium Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pfizer/Astellas (Inst); Seagen (Inst); Taiho Oncology (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer